<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03887299</url>
  </required_header>
  <id_info>
    <org_study_id>18-0265</org_study_id>
    <nct_id>NCT03887299</nct_id>
  </id_info>
  <brief_title>Antimicrobial Dressing Versus Standard Dressing in Obese Women Undergoing Cesarean Delivery</brief_title>
  <official_title>Antimicrobial Dressing Versus Standard Dressing in Obese Women Undergoing Cesarean Delivery: A Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Medical Branch, Galveston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Medical Branch, Galveston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be an open label pilot randomized controlled clinical trial. Women undergoing&#xD;
      cesarean delivery will be randomized to have standard wound dressing care or chlorohexidine&#xD;
      gluconate (CHG) impregnated wound dressing (ReliaTect™ Post-Op Dressing).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects requiring cesarean delivery and without exclusion criteria will be informed by the&#xD;
      obstetrical team about the study and asked for permission to contact the study personnel.&#xD;
      Written informed consent will be obtained by person-to-person contact. The research staff&#xD;
      will be responsible for the informed consent.&#xD;
&#xD;
      Subjects who agree to participate in the study will be randomized to one of the two groups&#xD;
      below in a 1/1 allocation:&#xD;
&#xD;
        -  Standard Wound Care: Wound dressing and care as per our current practice. Compression&#xD;
           dressing consisting of gauze, tefla and adhesive tape will be placed intraoperatively.&#xD;
           Dressing will be removed after 24 hours from surgery completion and subjects will have&#xD;
           an absorption pad with overlying garments for the remaining postoperative days until&#xD;
           standard postoperative visit for wound check.&#xD;
&#xD;
        -  CHG Wound Care: ReliaTect™ Post-Op Dressing will be applied as per the manufacturer's&#xD;
           instructions (Appendix A) intraoperatively. The dressing will be in place until the&#xD;
           postoperative clinic visit on postoperative day 7.&#xD;
&#xD;
      The remainder of the subjects' care will be similar for both arms and will follow current&#xD;
      standard clinical practice at the University of Texas Medical Branch (UTMB).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 18, 2019</start_date>
  <completion_date type="Actual">February 28, 2020</completion_date>
  <primary_completion_date type="Actual">January 18, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Open label randomized control trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Data analysis will be blinded to assignment including the principal investigator.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Satisfaction and QoL Questionnaire</measure>
    <time_frame>Postpartum wound care visit (up to 10days postpartum)</time_frame>
    <description>We will be assessing through a survey patient satisfaction concerning dressing received and assess the quality of life while receiving either intervention (5 point Richter scale). A maximum score of 5: Strongly agree and a minimum score of 1: Strongly disagree.&#xD;
A higher score means a better outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Composite Wound Complication</measure>
    <time_frame>30 days postpartum</time_frame>
    <description>Defined as presence of any of the following within 30 days from surgery: Wound infection: Presence of either superficial or deep incisional SSI described as cellulitis/erythema and induration around the incision or purulent discharge from the incision site, with or without fever, such as necrotizing fasciitis (diagnosed based on necrotizing wound infection). Wound hematoma, seroma, or breakdown alone. (yes or No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Wound Breakdown</measure>
    <time_frame>30 days postpartum</time_frame>
    <description>Opening of wound incision documented in the chart at the provider's discretion(Yes or No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants That Resulted in Maternal Death</measure>
    <time_frame>4 days postpartum</time_frame>
    <description>Death of participant during hospital stay (Yes or No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Puerperal Fever</measure>
    <time_frame>4 days postpartum</time_frame>
    <description>Temperature &gt; 100.4oF after first 24 hours or ≥101 oF any time. (Yes or No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Provider Satisfaction</measure>
    <time_frame>Postpartum wound care visit (up to 10days postpartum)</time_frame>
    <description>Assessing health care providers opinion on the dressing care (5 point Richter scale). A maximum score of 5: Strongly agree and a minimum score of 1: Strongly disagree.&#xD;
A higher score means a better outcome.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">154</enrollment>
  <condition>Cesarean Section Complications</condition>
  <condition>Wound Breakdown</condition>
  <condition>Wound Infection</condition>
  <condition>Satisfaction</condition>
  <condition>Surgical Wound Infection</condition>
  <arm_group>
    <arm_group_label>Standard Wound Care</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Wound dressing and care as per our current practice. Compression dressing consisting of gauze, tefla and adhesive tape will be placed intraoperatively. Dressing will be removed after 24 hours from surgery completion and subjects will have an absorption pad with overlying garments for the remaining postoperative days until standard postoperative visit for wound check.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CHG Wound Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ReliaTect™ Post-Op Dressing will be applied as per the manufacturer's instructions intraoperatively. The dressing will be in place until the postoperative clinic visit on postoperative day 7.</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG)</intervention_name>
    <description>Dressing will be applied in the operating room at the end of case and be in place until postoperative day 7</description>
    <arm_group_label>CHG Wound Care</arm_group_label>
    <other_name>Dressing containing CHG a disinfectant and antiseptic that is used for skin disinfection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Wound Care</intervention_name>
    <description>Wound care will be administered as standard protocol in our institution</description>
    <arm_group_label>Standard Wound Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18-50 years of age.&#xD;
&#xD;
          -  Women ≥ 24 weeks' viable gestation.&#xD;
&#xD;
          -  To undergo cesarean delivery.&#xD;
&#xD;
          -  Admission BMI ≥ 35.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient unwilling or unable to provide consent.&#xD;
&#xD;
          -  No prenatal care or a non-resident patient who is unlikely to be followed-up after&#xD;
             delivery.&#xD;
&#xD;
          -  Immunosuppressed subjects: i.e., taking systemic immunosuppressant or steroids (e.g.&#xD;
             transplant subjects; not including steroids for lung maturity), HIV with CD4 &lt;200, or&#xD;
             other.&#xD;
&#xD;
          -  Decision not to have skin closure (e.g. secondary wound closure, mesh closure).&#xD;
&#xD;
          -  Current skin infection.&#xD;
&#xD;
          -  Coagulopathy.&#xD;
&#xD;
          -  High likelihood of additional surgical procedure beyond cesarean (e.g. scheduled&#xD;
             hysterectomy, bowel or adnexal surgery).&#xD;
&#xD;
          -  Known allergy to CHG.&#xD;
&#xD;
          -  Incarcerated individuals.&#xD;
&#xD;
          -  Chorioamnionitis.&#xD;
&#xD;
          -  Subjects participating on other treatment trials or studies that would interfere with&#xD;
             the current study's primary outcome.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Obstetrical population: Pregnant women undergoing cesarean section</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio F. Saad, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UTMB Galveston</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ashley Salazar</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Allegranzi B, Zayed B, Bischoff P, Kubilay NZ, de Jonge S, de Vries F, Gomes SM, Gans S, Wallert ED, Wu X, Abbas M, Boermeester MA, Dellinger EP, Egger M, Gastmeier P, Guirao X, Ren J, Pittet D, Solomkin JS; WHO Guidelines Development Group. New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis. 2016 Dec;16(12):e288-e303. doi: 10.1016/S1473-3099(16)30402-9. Epub 2016 Nov 2. Review.</citation>
    <PMID>27816414</PMID>
  </reference>
  <reference>
    <citation>Berg CJ, Chang J, Callaghan WM, Whitehead SJ. Pregnancy-related mortality in the United States, 1991-1997. Obstet Gynecol. 2003 Feb;101(2):289-96.</citation>
    <PMID>12576252</PMID>
  </reference>
  <reference>
    <citation>DeFrances CJ, Cullen KA, Kozak LJ. National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13. 2007 Dec;(165):1-209.</citation>
    <PMID>18350768</PMID>
  </reference>
  <reference>
    <citation>Gibbs RS. Clinical risk factors for puerperal infection. Obstet Gynecol. 1980 May;55(5 Suppl):178S-184S. Review.</citation>
    <PMID>6990333</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 21, 2019</study_first_submitted>
  <study_first_submitted_qc>March 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2019</study_first_posted>
  <results_first_submitted>April 5, 2021</results_first_submitted>
  <results_first_submitted_qc>September 7, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">October 5, 2021</results_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cesarean</keyword>
  <keyword>Wound care</keyword>
  <keyword>Wound complication</keyword>
  <keyword>Surgical site infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Wound Infection</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
    <mesh_term>Surgical Wound Dehiscence</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Surgical Wound</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disinfectants</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 11, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/99/NCT03887299/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard Wound Care</title>
          <description>Wound dressing and care as per our current practice. Compression dressing consisting of gauze, tefla and adhesive tape will be placed intraoperatively. Dressing will be removed after 24 hours from surgery completion and subjects will have an absorption pad with overlying garments for the remaining postoperative days until standard postoperative visit for wound check.&#xD;
Standard Wound Care: Wound care will be administered as standard protocol in our institution</description>
        </group>
        <group group_id="P2">
          <title>CHG Wound Care</title>
          <description>ReliaTect™ Post-Op Dressing will be applied as per the manufacturer's instructions intraoperatively. The dressing will be in place until the postoperative clinic visit on postoperative day 7.&#xD;
ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG): Dressing will be applied in the operating room at the end of case and be in place until postoperative day 7</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="77"/>
                <participants group_id="P2" count="77"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="77"/>
                <participants group_id="P2" count="77"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard Wound Care</title>
          <description>Wound dressing and care as per our current practice. Compression dressing consisting of gauze, tefla and adhesive tape will be placed intraoperatively. Dressing will be removed after 24 hours from surgery completion and subjects will have an absorption pad with overlying garments for the remaining postoperative days until standard postoperative visit for wound check.&#xD;
Standard Wound Care: Wound care will be administered as standard protocol in our institution</description>
        </group>
        <group group_id="B2">
          <title>CHG Wound Care</title>
          <description>ReliaTect™ Post-Op Dressing will be applied as per the manufacturer's instructions intraoperatively. The dressing will be in place until the postoperative clinic visit on postoperative day 7.&#xD;
ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG): Dressing will be applied in the operating room at the end of case and be in place until postoperative day 7</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="77"/>
            <count group_id="B2" value="77"/>
            <count group_id="B3" value="154"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29" lower_limit="20" upper_limit="41"/>
                    <measurement group_id="B2" value="29" lower_limit="19" upper_limit="41"/>
                    <measurement group_id="B3" value="29" lower_limit="19" upper_limit="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="77"/>
                    <measurement group_id="B2" value="77"/>
                    <measurement group_id="B3" value="154"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="84"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="70"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="77"/>
                    <measurement group_id="B2" value="77"/>
                    <measurement group_id="B3" value="154"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Medical Condition</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Delivery complications</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Vertical Skin incision</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Skin closure with staples</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Satisfaction and QoL Questionnaire</title>
        <description>We will be assessing through a survey patient satisfaction concerning dressing received and assess the quality of life while receiving either intervention (5 point Richter scale). A maximum score of 5: Strongly agree and a minimum score of 1: Strongly disagree.&#xD;
A higher score means a better outcome.</description>
        <time_frame>Postpartum wound care visit (up to 10days postpartum)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Wound Care</title>
            <description>Wound dressing and care as per our current practice. Compression dressing consisting of gauze, tefla and adhesive tape will be placed intraoperatively. Dressing will be removed after 24 hours from surgery completion and subjects will have an absorption pad with overlying garments for the remaining postoperative days until standard postoperative visit for wound check.&#xD;
Standard Wound Care: Wound care will be administered as standard protocol in our institution</description>
          </group>
          <group group_id="O2">
            <title>CHG Wound Care</title>
            <description>ReliaTect™ Post-Op Dressing will be applied as per the manufacturer's instructions intraoperatively. The dressing will be in place until the postoperative clinic visit on postoperative day 7.&#xD;
ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG): Dressing will be applied in the operating room at the end of case and be in place until postoperative day 7</description>
          </group>
        </group_list>
        <measure>
          <title>Satisfaction and QoL Questionnaire</title>
          <description>We will be assessing through a survey patient satisfaction concerning dressing received and assess the quality of life while receiving either intervention (5 point Richter scale). A maximum score of 5: Strongly agree and a minimum score of 1: Strongly disagree.&#xD;
A higher score means a better outcome.</description>
          <units>Score</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="77"/>
                <count group_id="O2" value="77"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49" lower_limit="20" upper_limit="55"/>
                    <measurement group_id="O2" value="52" lower_limit="12" upper_limit="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Composite Wound Complication</title>
        <description>Defined as presence of any of the following within 30 days from surgery: Wound infection: Presence of either superficial or deep incisional SSI described as cellulitis/erythema and induration around the incision or purulent discharge from the incision site, with or without fever, such as necrotizing fasciitis (diagnosed based on necrotizing wound infection). Wound hematoma, seroma, or breakdown alone. (yes or No)</description>
        <time_frame>30 days postpartum</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Wound Care</title>
            <description>Wound dressing and care as per our current practice. Compression dressing consisting of gauze, tefla and adhesive tape will be placed intraoperatively. Dressing will be removed after 24 hours from surgery completion and subjects will have an absorption pad with overlying garments for the remaining postoperative days until standard postoperative visit for wound check.&#xD;
Standard Wound Care: Wound care will be administered as standard protocol in our institution</description>
          </group>
          <group group_id="O2">
            <title>CHG Wound Care</title>
            <description>ReliaTect™ Post-Op Dressing will be applied as per the manufacturer's instructions intraoperatively. The dressing will be in place until the postoperative clinic visit on postoperative day 7.&#xD;
ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG): Dressing will be applied in the operating room at the end of case and be in place until postoperative day 7</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Composite Wound Complication</title>
          <description>Defined as presence of any of the following within 30 days from surgery: Wound infection: Presence of either superficial or deep incisional SSI described as cellulitis/erythema and induration around the incision or purulent discharge from the incision site, with or without fever, such as necrotizing fasciitis (diagnosed based on necrotizing wound infection). Wound hematoma, seroma, or breakdown alone. (yes or No)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="77"/>
                <count group_id="O2" value="77"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Wound Breakdown</title>
        <description>Opening of wound incision documented in the chart at the provider's discretion(Yes or No)</description>
        <time_frame>30 days postpartum</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Wound Care</title>
            <description>Wound dressing and care as per our current practice. Compression dressing consisting of gauze, tefla and adhesive tape will be placed intraoperatively. Dressing will be removed after 24 hours from surgery completion and subjects will have an absorption pad with overlying garments for the remaining postoperative days until standard postoperative visit for wound check.&#xD;
Standard Wound Care: Wound care will be administered as standard protocol in our institution</description>
          </group>
          <group group_id="O2">
            <title>CHG Wound Care</title>
            <description>ReliaTect™ Post-Op Dressing will be applied as per the manufacturer's instructions intraoperatively. The dressing will be in place until the postoperative clinic visit on postoperative day 7.&#xD;
ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG): Dressing will be applied in the operating room at the end of case and be in place until postoperative day 7</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Wound Breakdown</title>
          <description>Opening of wound incision documented in the chart at the provider's discretion(Yes or No)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="77"/>
                <count group_id="O2" value="77"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants That Resulted in Maternal Death</title>
        <description>Death of participant during hospital stay (Yes or No)</description>
        <time_frame>4 days postpartum</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Wound Care</title>
            <description>Wound dressing and care as per our current practice. Compression dressing consisting of gauze, tefla and adhesive tape will be placed intraoperatively. Dressing will be removed after 24 hours from surgery completion and subjects will have an absorption pad with overlying garments for the remaining postoperative days until standard postoperative visit for wound check.&#xD;
Standard Wound Care: Wound care will be administered as standard protocol in our institution</description>
          </group>
          <group group_id="O2">
            <title>CHG Wound Care</title>
            <description>ReliaTect™ Post-Op Dressing will be applied as per the manufacturer's instructions intraoperatively. The dressing will be in place until the postoperative clinic visit on postoperative day 7.&#xD;
ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG): Dressing will be applied in the operating room at the end of case and be in place until postoperative day 7</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants That Resulted in Maternal Death</title>
          <description>Death of participant during hospital stay (Yes or No)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="77"/>
                <count group_id="O2" value="77"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Puerperal Fever</title>
        <description>Temperature &gt; 100.4oF after first 24 hours or ≥101 oF any time. (Yes or No)</description>
        <time_frame>4 days postpartum</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Wound Care</title>
            <description>Wound dressing and care as per our current practice. Compression dressing consisting of gauze, tefla and adhesive tape will be placed intraoperatively. Dressing will be removed after 24 hours from surgery completion and subjects will have an absorption pad with overlying garments for the remaining postoperative days until standard postoperative visit for wound check.&#xD;
Standard Wound Care: Wound care will be administered as standard protocol in our institution</description>
          </group>
          <group group_id="O2">
            <title>CHG Wound Care</title>
            <description>ReliaTect™ Post-Op Dressing will be applied as per the manufacturer's instructions intraoperatively. The dressing will be in place until the postoperative clinic visit on postoperative day 7.&#xD;
ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG): Dressing will be applied in the operating room at the end of case and be in place until postoperative day 7</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Puerperal Fever</title>
          <description>Temperature &gt; 100.4oF after first 24 hours or ≥101 oF any time. (Yes or No)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="77"/>
                <count group_id="O2" value="77"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Provider Satisfaction</title>
        <description>Assessing health care providers opinion on the dressing care (5 point Richter scale). A maximum score of 5: Strongly agree and a minimum score of 1: Strongly disagree.&#xD;
A higher score means a better outcome.</description>
        <time_frame>Postpartum wound care visit (up to 10days postpartum)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Wound Care</title>
            <description>Wound dressing and care as per our current practice. Compression dressing consisting of gauze, tefla and adhesive tape will be placed intraoperatively. Dressing will be removed after 24 hours from surgery completion and subjects will have an absorption pad with overlying garments for the remaining postoperative days until standard postoperative visit for wound check.&#xD;
Standard Wound Care: Wound care will be administered as standard protocol in our institution</description>
          </group>
          <group group_id="O2">
            <title>CHG Wound Care</title>
            <description>ReliaTect™ Post-Op Dressing will be applied as per the manufacturer's instructions intraoperatively. The dressing will be in place until the postoperative clinic visit on postoperative day 7.&#xD;
ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG): Dressing will be applied in the operating room at the end of case and be in place until postoperative day 7</description>
          </group>
        </group_list>
        <measure>
          <title>Provider Satisfaction</title>
          <description>Assessing health care providers opinion on the dressing care (5 point Richter scale). A maximum score of 5: Strongly agree and a minimum score of 1: Strongly disagree.&#xD;
A higher score means a better outcome.</description>
          <units>Score</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="77"/>
                <count group_id="O2" value="77"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17" lower_limit="5" upper_limit="25"/>
                    <measurement group_id="O2" value="21" lower_limit="5" upper_limit="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data was collected up to 9 months from subject randomization.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Standard Wound Care</title>
          <description>Wound dressing and care as per our current practice. Compression dressing consisting of gauze, tefla and adhesive tape will be placed intraoperatively. Dressing will be removed after 24 hours from surgery completion and subjects will have an absorption pad with overlying garments for the remaining postoperative days until standard postoperative visit for wound check.&#xD;
Standard Wound Care: Wound care will be administered as standard protocol in our institution</description>
        </group>
        <group group_id="E2">
          <title>CHG Wound Care</title>
          <description>ReliaTect™ Post-Op Dressing will be applied as per the manufacturer's instructions intraoperatively. The dressing will be in place until the postoperative clinic visit on postoperative day 7.&#xD;
ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG): Dressing will be applied in the operating room at the end of case and be in place until postoperative day 7</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="77"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="77"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="77"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Antonio F Saad</name_or_title>
      <organization>University of Texas Medical Branch Galveston</organization>
      <phone>4097476646</phone>
      <email>afsaad@utmb.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

